Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 338 publications

Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity.

Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity.

Journal: Neurology and therapy
Published: August 05, 2025

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 23, 2025

The Role of Novel Small Molecule Drugs in the Management of Inflammatory Bowel Disease.

The Role of Novel Small Molecule Drugs in the Management of Inflammatory Bowel Disease.

Journal: British journal of hospital medicine (London, England : 2005)
Published: June 24, 2025

Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory Diseases.

Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory Diseases.

Journal: Deutsches Arzteblatt international
Published: June 17, 2025

Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory Diseases.

Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory Diseases.

Journal: Deutsches Arzteblatt international
Published: June 17, 2025

The effect of disease-modifying therapies on brain volume loss and disability accumulation in multiple sclerosis: a systematic review and network meta-analysis.

The effect of disease-modifying therapies on brain volume loss and disability accumulation in multiple sclerosis: a systematic review and network meta-analysis.

Journal: The Lancet regional health. Europe
Published: May 30, 2025

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.

Journal: Journal of neurology
Published: May 23, 2025

Macrophage-TREM2 promotes cardiac repair by restricting the infiltration of CD8+ T cells via CXCL16-CXCR6 axis after myocardial infarction.

Macrophage-TREM2 promotes cardiac repair by restricting the infiltration of CD8+ T cells via CXCL16-CXCR6 axis after myocardial infarction.

Journal: Theranostics
Published: May 21, 2025

Clinical Status and CNS Adverse Drug Report of Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis.

Clinical Status and CNS Adverse Drug Report of Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis.

Journal: Drug discovery today
Published: May 07, 2025

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid.

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid.

Journal: Inflammatory bowel diseases
Published: April 18, 2025

Contribution of S1pr1 -featured astrocyte subpopulation to cisplatin-induced neuropathic pain.

Contribution of S1pr1 -featured astrocyte subpopulation to cisplatin-induced neuropathic pain.

Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025

S1P Receptor Modulators Improve Clinical Outcomes in Ulcerative Colitis: A Stratified Meta-Analysis By Prior Biological Use, Corticosteroid Exposure, and Disease Characteristics.

S1P Receptor Modulators Improve Clinical Outcomes in Ulcerative Colitis: A Stratified Meta-Analysis By Prior Biological Use, Corticosteroid Exposure, and Disease Characteristics.

Journal: Journal of clinical gastroenterology
Published: April 10, 2025
Showing 1-12 of 338

Last Updated: 10/31/2025